openPR Logo
Press release

Vagus Nerve Stimulators Market Outlook 2025-2031: Trends, Growth Drivers, and Key Innovations | Top Companies are Medtronic PLC, Electrocore LLC, Livanova PLC.

06-25-2025 08:49 AM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

Vagus Nerve Stimulators Market

Vagus Nerve Stimulators Market

Global Vagus Nerve Stimulators market is expected to grow at a CAGR Of 8.9% during the forecast period 2024-2031.

The Vagus Nerve Stimulators Market takes center stage in DataM Intelligence's latest comprehensive research, where industry experts deliver cutting-edge analysis powered by robust data analytics and strategic market intelligence. This groundbreaking study dives deep into the competitive ecosystem, spotlighting market leaders and their innovative approaches to product development, competitive pricing models, financial performance, and expansion strategies. The research unveils critical market forces, competitive positioning, and breakthrough trends that will define the industry's trajectory in the coming years, providing stakeholders with actionable intelligence to navigate this rapidly evolving marketplace.

Unlock exclusive insights with our detailed sample report (Please enter your Corporate Email ID to get priority access):- https://datamintelligence.com/download-sample/vagus-nerve-stimulators-market?rk

The Vagus Nerve Stimulators (VNS) Market refers to the segment of medical devices designed to deliver electrical impulses to the vagus nerve, primarily for the treatment of neurological disorders. These devices are typically implantable and are used to manage conditions such as epilepsy, treatment-resistant depression, migraine, and emerging indications like inflammatory diseases and obesity.

Key Market Trends:
Rising prevalence of epilepsy and depression is driving demand for VNS devices, especially among treatment-resistant patient populations.

Shift toward non-invasive VNS (nVNS) devices is gaining popularity due to patient comfort, lower risk, and outpatient usability.

Technological advancements include miniaturized implantable devices, personalized stimulation parameters, and real-time data monitoring via apps.

Expanding indications - VNS is being explored in clinical trials for conditions like anxiety disorders, PTSD, Alzheimer's, and inflammatory bowel disease.

Vagus Nerve Stimulators Market: Industry Giants and Emerging Leaders:

Medtronic PLC, Electrocore LLC, Livanova PLC, Boston Scientific Corporation, Aleva Neurotherapeutics SA, Biocontrol Medical, Bioness Inc., Enteromedics Inc., Nevro Corporation, and Neuropace Inc.

Vagus Nerve Stimulators Industry News:

LivaNova plc continues to lead the market with its next-gen SenTiva DUO system, offering enhanced battery life and multi-parameter sensing for epilepsy.

In March 2024, electroCore, Inc. received FDA clearance for expanded use of its non-invasive gammaCoreTM device for migraine and cluster headaches.

SetPoint Medical is advancing trials for its bioelectronic VNS therapy in autoimmune diseases such as rheumatoid arthritis and Crohn's disease, showing positive early results.

Research Methodology

Our comprehensive research approach leverages a dual-methodology framework that seamlessly integrates qualitative insights with quantitative data analysis to deliver robust market intelligence. The process begins with extensive secondary research, where we meticulously collect information from authoritative industry publications, proprietary databases, and verified market sources. This foundation is strengthened through targeted primary research initiatives, including strategic surveys and in-depth interviews with industry veterans, market experts, and key stakeholders.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/vagus-nerve-stimulators-market

Segment Covered in the Vagus Nerve Stimulators Market:

By Type: Implantable VNS Devices and External VNS Devices

By Application: Depression, Epilepsy, and Migraine

By End-User: Hospitals, Ambulatory Surgical Centers (ASCs), and Others

By Biomaterial: Ceramics, Metallic, and Polymeric

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, Market Access, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Top-down and bottom-up approach for regional analysis

Regional Analysis for Vagus Nerve Stimulators Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)



Frequently asked questions:

➠ What is the global sales value, production value, consumption value, import and export of Vagus Nerve Stimulators market?

➠ Who are the global key manufacturers of the Vagus Nerve Stimulators Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?

➠ What are the Vagus Nerve Stimulators market opportunities and threats faced by the vendors in the global Vagus Nerve Stimulators Industry?

➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?

➠ What focused approach and constraints are holding the Vagus Nerve Stimulators market?

➠ What are the different sales, marketing, and distribution channels in the global industry?

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription

Looking For Detailed Full Report? Get it here: https://datamintelligence.com/buy-now-page?report=vagus-nerve-stimulators-market

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Vagus Nerve Stimulators Market Outlook 2025-2031: Trends, Growth Drivers, and Key Innovations | Top Companies are Medtronic PLC, Electrocore LLC, Livanova PLC. here

News-ID: 4080953 • Views:

More Releases from DataM Intelligence 4market Research LLP

United States Exocrine Pancreatic Insufficiency Treatment Market 2024-2031: Comprehensive Analysis of Pancreatic Enzyme Replacement Therapy, Nutritional Management, Emerging Therapies, and Strategic Growth Opportunities
United States Exocrine Pancreatic Insufficiency Treatment Market 2024-2031: Comp …
The Global Exocrine Pancreatic Insufficiency Treatment Market reached US$ 3.30 billion in 2023 and is expected to reach US$ 5.37 billion by 2031, growing at a CAGR of 6.4% during the forecast period 2024-2031. Exocrine Pancreatic Insufficiency (EPI) is a condition where the pancreas fails to produce sufficient digestive enzymes, leading to malabsorption, nutrient deficiencies, and gastrointestinal issues. Treatments primarily involve pancreatic enzyme replacement therapy (PERT), dietary modifications, and adjunctive nutritional
Herpes Labialis Drugs Market 2024-2031: Comprehensive Analysis of Antiviral Therapeutics, Topical and Oral Formulations, Emerging Therapies, and Strategic Market Opportunities | GlaxoSmithKline Pharmaceuticals, Bauch Health Inc., Novartis AG
Herpes Labialis Drugs Market 2024-2031: Comprehensive Analysis of Antiviral Ther …
The global herpes labialis drugs market reached US$ 1.16 billion in 2023 and is expected to reach US$ 1.7 billion by 2031 growing with a CAGR of 4.8% during the forecast period 2024-2031. Herpes labialis, commonly known as cold sores, is caused by the Herpes Simplex Virus-1 (HSV-1). Treatment options include antiviral drugs such as acyclovir, valacyclovir, famciclovir, and topical formulations, which help reduce symptoms, accelerate healing, and prevent recurrence. The
United States Chronic Inflammatory Demyelinating Polyneuropathy Market 2024-2031: In-Depth Analysis of Immunoglobulin Therapy, Corticosteroids, Plasma Exchange, and Emerging Biologics | Top Companies are Grifols, Baxter, Kedrion S.p.A
United States Chronic Inflammatory Demyelinating Polyneuropathy Market 2024-2031 …
Chronic Inflammatory Demyelinating Polyneuropathy Market is valued at a significant CAGR during the forecast period (2024-2031). Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare autoimmune disorder that leads to progressive weakness, numbness, and sensory impairment in the limbs. Current treatments include corticosteroids, intravenous immunoglobulin (IVIg), plasma exchange (plasmapheresis), and emerging biologics. The market is expanding due to increasing disease awareness, advances in therapeutic options, early diagnosis, and growing adoption of patient-centric
United States Varicella Zoster Infections Treatment Market 2024-2031: In-Depth Analysis of Antivirals, Vaccines, Pain Management Therapies, and Emerging Therapeutic Innovations | Bausch Health Companies Inc., LNHC, Inc., GSK plc.
United States Varicella Zoster Infections Treatment Market 2024-2031: In-Depth A …
Global Varicella Zoster Infections Treatment Market reached US$ 1,799.42 million in 2023 and is expected to reach US$ 2,523.90 million by 2031, growing at a CAGR of 4.3% during the forecast period 2024-2031. Varicella Zoster Virus (HHV-3) causes chickenpox (varicella) and shingles (herpes zoster). Treatments include antiviral drugs (acyclovir, valacyclovir, famciclovir), vaccines, and pain management therapies to prevent complications and manage symptoms. The market is growing due to increasing prevalence of

All 5 Releases


More Releases for Vagus

Emerging Trends Influencing The Growth Of The Vagus Nerve Stimulation Market: In …
"The Vagus Nerve Stimulation Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. How Big Is the Vagus Nerve Stimulation Market Size Expected to Be by 2034? The market size for vagus nerve stimulation has experienced swift expansion in the recent past. A growth trajectory is predicted
Top Factor Driving Vagus Nerve Stimulation Market Growth in 2025: Increasing Pre …
How Big Is the Vagus Nerve Stimulation Market Expected to Be, and What Will Its Growth Rate Be? In recent times, there has been significant growth in the vagus nerve stimulation market. This market, which was worth $0.89 billion in 2024, is projected to rise to $1.02 billion in 2025, representing a compound annual growth rate (CAGR) of 14.9%. The historic growth is credited to several factors including an escalating aging
Vagus Nerve Stimulation Market Size, Share, Growth | Report, 2027
Latest Updated Report 2023, The Global Vagus Nerve Stimulation Market to Growing A CAGR of % during forecast period of 2023-2027. The Market is segmented by Global Vagus Nerve Stimulation Market Breakdown by Application (Hospitals And Surgical Centers, Ambulatory Surgical Centers) by Type (General Type) and by Geography (North America, South America, Europe, Asia Pacific, MEA). The Vagus Nerve Stimulation Market 2023 Report makes available the current and forthcoming technical and
Vagus Nerve Stimulation Devices Market 2021 | Detailed Report
The Vagus Nerve Stimulation Devices research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market’s key players. Furthermore, the report offers insightful market data and information about the
Vagus Nerve Stimulators Market Scope Assessment 2028
Global Vagus Nerve Stimulators Market: Overview Increasing number of neurological diseases especially in developing economies is the key factor driving demand in the global vagus nerve stimulators market. Use of vagus nerve stimulation therapy helps in reducing neurological conditions such as neurological tremors and dyskinesia. Its application is also seen in while controlling bladder difficulties, restoration of hand gasp, and improves movement. Get Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=5396 According to the
Vagus Nerve Stimulators Market Growth, Size & Forecast to 2025
Vagus nerve stimulator market is expected to grow at a CAGR of 3.8% during the forecast period. Vagus nerve stimulator are those devices that are utilized to stimulate the vagus nerve with electrical impulses. It is used to treat epilepsy and depression. In vagus nerve stimulation, the stimulator is surgically implanted under the skin on the chest, and the device is connected to the left vagus nerve through a wire